Added to YB: 2026-02-05
Pitch date: 2026-02-03
INMD [neutral]
InMode Ltd.
-4.76%
current return
Author Info
No bio for this author
Company Info
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally.
Market Cap
$1.1B
Pitch Price
$15.85
Price Target
15.80 (+5%)
Dividend
N/A
EV/EBITDA
5.72
P/E
7.51
EV/Sales
1.44
Sector
Health Care Equipment and Supplies
Category
special_situation
InMode (INMD): Low-risk Take-Private Opportunity
INMD: Steel Partners bids $18/share for 51%, PE bidders offer $16-17/share ($1-1.1B) with mid-Feb deadline. Sofwave taking share but InMode has $532M net cash, 27K installed base. SG&A bloated at 51% vs 35% historical - $60M savings potential. LBO-shaped: 3.6x EBITDA ex-cash post-cuts.
Read full article (4 min)